QT Vascular subsidiary TriReme Medical touted angiographic data today from a 24-month follow-up of patients treated with its Chocolate Heart drug-coated balloon. The Chocolate Heart device is a paclitaxel-coated version of the company’s Chocolate coronary balloon that is commercially available in the U.S. The combo therapy was designed to reduce the incidence of repeat procedures […]
TriReme Medical Inc.
QT Vascular subsidiary TriReme lands GPO deal with HealthTrust
QT Vascular said yesterday that its TriReme Medical subsidiary inked a group purchase agreement with Healthtrust Purchasing Group. Through the newly signed deal, Healthtrust will gain access to TriReme’s portfolio of specialty angioplasty balloons designed to treat blood vessel blockage due to arterial disease, QT Vascular said. Nashville, Tenn.-based HealthTrust serves more than 1,400 acute care […]
Appeals court reverses AngioScore win over TriReme
The U.S. Court of Appeals for the Federal Circuit overturned a ruling in favor of AngioScore in a patent infringement case between it and TriReme Medical and a pair of related companies. The court ruled that an earlier decision from the United States District Court for the Northern District of California “improperly exercised supplemental jurisdiction over state-law […]
Appeals court tosses $20m AngioScore win over TriReme Medical
A federal appeals court yesterday tossed AngioScore‘s $20 million win over TriReme Medical and a pair of related companies, ruling that the case never should have made it to the federal level. Just more than a year ago, Judge Yvonne Gonzalez Rogers of the U.S. District Court for Northern California ruled that AngioScore founder Eitan Konstantino violated his duties to AngioScore when […]
Appeals court reverses TriReme patent loss to AngioScore
CORRECTED July 22, 2016. This article originally transposed the patent infringement lawsuit filed by TriReme against AngioScore for a breach-of-contract lawsuit filed by AngioScore. A federal appeals court today reversed a lower court’s patent infringement ruling that went against TriReme Medical and a pair of related companies in favor of AngioScore, sending the case back to a lower court […]
TriReme, founder win AngioScore patent spat, lose bid for legal fees
AngioScore lost the patent infringement portion of its legal war with co-founder and former board member Eitan Konstantino, but won’t have to pay its opponents’ $4.8 million legal tab, a federal judge ruled this week. AngioScore, which accused Konstantino of violating his fiduciary duties when he started TriReme Medical, Quattro Vascular and QT Vascular, won a $20 million […]
QT Vascular wins stay in $20m loss to AngioScore
QT Vascular and a pair of related companies last week won a stay in their $20 million loss to AngioScore so their appeal can proceed. In July, a federal judge ruled that founder Eitan Konstantino violated his duties to AngioScore when he started QT Vascular, TriReme Medical and Quattro Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for $230 million, accused Konstantino of breaching his fiduciary duties […]
TriReme appeals $20m loss to AngioScore
TriReme Medical and a pair of related companies are appealing a $20 million loss to AngioScore after a federal judge ruled that founder Eitan Konstantino violated his duties to AngioScore when he started TriReme, Quattro Vascular and QT Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for $230 million, accused Konstantino of breaching his fiduciary duties to AngioScore by developing the TriReme’s Chocolate balloon catheter, […]
UPDATE: Spectranetics’ AngioScore wins $20m from Trireme, founder Konstantino
UDATED July 8, 2015, with comment from QT Vascular, stock performance. AngioScore last week won a $20 million judgment against co-founder and former board member Eitan Konstantino, after a federal judge ruled that Konstantino violated his duties to AngioScore when he started TriReme Medical, Quattro Vascular and QT Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for […]
Singapore’s QT Vascular buys Israeli TAVI tech
QT Vascular said it acquired a new technology platform created by an undisclosed developer in Israel called Java that it plans to develop as an aortic valvuloplasty balloon for transcatheter aortic valve implants.
TriReme lands FDA nod for new Chocolate PTCA balloon catheter
Singapore medical device maker and QT Vascular subsidiary TriReme Medical won FDA clearance for its Chocolate PTCA balloon catheter, the latest in the company’s line of minimally invasive vascular disease treatment products.
